Michael Celano insider trades

Open-market stock purchases and sales by Michael Celano, Chief Financial Officer at Larimar Therapeutics, Inc, from SEC Form 4 filings since Jan 23, 2010.

Track record: 0% of 3 scored buys are up 5% or more since purchase, averaging -27%.

Recent trades

DateStockTradeValue
Jan 26, 2026LRMR Larimar Therapeutics, IncBought (not open market)—
Jan 26, 2026LRMR Larimar Therapeutics, IncBought (not open market)—

Companies traded

  • LRMR Larimar Therapeutics, Inc: 2 buys, last Jan 26, 2026
  • OSUR Orasure Technologies Inc: 1 buy, 4 sales, last Aug 12, 2022
  • REPH Recro Pharma, Inc: other filings, last Jan 18, 2019
  • KNSY Kensey Nash Corp: other filings, last Jun 22, 2012

Get free alerts when Michael Celano files a new trade →